Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma.
| Author | |
|---|---|
| Abstract | :
The New Approaches to Neuroblastoma Therapy Response Criteria (NANTRC) were developed to optimize response assessment in patients with recurrent/refractory neuroblastoma. Response predictors and associations of the NANTRC version 1.0 (NANTRCv1.0) and prognostic factors with outcome were analyzed. |
| Year of Publication | :
2018
|
| Journal | :
Pediatric blood & cancer
|
| Date Published | :
2018
|
| ISSN Number | :
1545-5009
|
| URL | :
http://dx.doi.org/10.1002/pbc.26940
|
| DOI | :
10.1002/pbc.26940
|
| Short Title | :
Pediatr Blood Cancer
|
| Download citation |